These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1666666)

  • 21. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
    Edwards PA; Hiby SE; Papkoff J; Bradbury JM
    Oncogene; 1992 Oct; 7(10):2041-51. PubMed ID: 1408145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function.
    Humphreys RC; Rosen JM
    Cell Growth Differ; 1997 Aug; 8(8):839-49. PubMed ID: 9269893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
    Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Int-5, a locus associated with early events in mammary carcinogenesis.
    Morris VL; Rao TR; Kozak CA; Gray DA; Lee Chan EC; Cornell TJ; Taylor CB; Jones RF; McGrath CM
    Oncogene Res; 1991; 6(1):53-63. PubMed ID: 1705320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
    Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G
    Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of viral antigens released into plasma and culture fluids by murine mammary tumor cells.
    Ritzi EM; Smith BA; Stolfi RL; Martin DS
    Cancer Res; 1981 Oct; 41(10):3885-90. PubMed ID: 6269731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
    Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
    Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse mammary tumor virus derived from wild mice does not target Notch-4 protooncogene for the development of mammary tumors in inbred mice.
    Sarkar NH
    Virology; 2009 May; 388(1):121-7. PubMed ID: 19329137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Wilburn D; Heppner GH
    Cancer Res; 1988 Oct; 48(20):5747-53. PubMed ID: 3167832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts.
    Sarkar NH; Haga S; Lehner AF; Zhao W; Imai S; Moriwaki K
    Virology; 1994 Aug; 203(1):52-62. PubMed ID: 8030284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
    Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of mammary tumor virus in hormone-dependent and -independent mouse mammary tumor cells.
    Sluyser M; Nouwen T; Hilgers J; Calafat J
    Cancer Res; 1977 Jul; 37(7 Pt 1):1986-90. PubMed ID: 193632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response of cultured mouse mammary cells of varying tumorigenicity to cytochalasin B.
    Steiner MR; Altenburg B; Richards CS; Dudley JP; Medina D; Butel JS
    Cancer Res; 1978 Sep; 38(9):2719-21. PubMed ID: 679176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro.
    Kittrell FS; Oborn CJ; Medina D
    Cancer Res; 1992 Apr; 52(7):1924-32. PubMed ID: 1372532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fate of clonal lineages during neoplasia and metastasis studied with an incorporated genetic marker.
    Moffett BF; Baban D; Bao L; Tarin D
    Cancer Res; 1992 Apr; 52(7):1737-43. PubMed ID: 1551102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.